Transcatheter closure of elongated and pulmonary hypertensive patent arterial duct in infants using Amplatzer vascular plug II

2020 ◽  
Vol 30 (2) ◽  
pp. 243-248 ◽  
Author(s):  
Sneha M. Jain ◽  
Priya M. Pradhan ◽  
Supratim Sen ◽  
Bharat V. Dalvi
Keyword(s):  
Pulmonary Artery ◽  
Amplatzer Vascular Plug ◽  
Successful Outcome ◽  
Pulmonary Artery Stenosis ◽  
Amplatzer Duct Occluder ◽  
Vascular Plug ◽  
Arterial Duct ◽  
Duct Diameter ◽  
Patent Arterial Duct ◽  
Amplatzer Vascular Plug Ii

AbstractObjective:To evaluate the feasibility, efficacy, and safety of Amplatzer vascular plug II in large and elongated ducts in infants.Introduction:Patent arterial duct device closure is technically challenging in infants with large and elongated ducts because Amplatzer duct occluder and Amplatzer duct occluder II have high chances of causing aortic coarctation and left pulmonary artery stenosis, respectively. The Amplatzer vascular plug II being soft with no retention discs on either sides helps in mitigating these problems.Method:This is a prospective, observational study involving infants with clinical, echocardiographic and angiographic evidence of large left to right shunt. All the children underwent duct closure using Amplatzer vascular plug II.Results:Eighteen infants qualified for the study. Mean age and weight were 8.63 ± 3.84 months and 6.3 ± 1.7 kg, respectively. The angiographic mean duct diameter at the pulmonary artery end was 4.66 ± 0.92 mm, and the mean duct length was 9.4 ± 2.48 mm. The size of Amplatzer vascular plug II used varied from 6 mm to 10 mm. Technical success was achieved in 16/18 cases. One patient had device embolisation, and in the other, the device was found to be unstable. The ratio of Amplatzer vascular plug II size to the duct diameter was 1.65 ± 0.27, while the ratio of ductal length to device length was 1.48 ± 0.46 in those with successful outcome.Conclusions:Amplatzer vascular plug II is a safe and effective option in appropriately selected infants with elongated ducts. Diameter and length of Amplatzer vascular plug II vis-a-vis those of the ductus are important determinants of the successful outcome.

Transcatheter closure of post-operative type 1 Gerbode defect by Amplatzer Duct Occluder 2

2021 ◽  
pp. 1-3
Author(s):  
Ahmet Vedat Kavurt ◽  
İbrahim Ece ◽  
Denizhan Bağrul
Keyword(s):  
Transcatheter Closure ◽  
Left Ventricular ◽  
Amplatzer Vascular Plug ◽  
Right Atrial ◽  
Amplatzer Duct Occluder ◽  
Vascular Plug ◽  
Gerbode Defect ◽  
Amplatzer Vascular Plug Ii

Abstract Acquired and congenital left ventricular to right atrial communication is rare, but nowadays, the frequency of the iatrogenic subgroup is increasing. Successful transcatheter closure of these defects with different devices has been reported. Herein, we presented successful closure of left ventricular to right atrial communication with Amplatzer Duct Occluder 2 after attempting to close with a failed Amplatzer Vascular Plug II device in a 7-year-old girl. This report supports that transcatheter closure of iatrogenic Gerbode defect with Amplatzer Duct Occluder 2 device is safe and effective.

Coil occlusion of the small patent arterial duct without arterial access

2002 ◽  
Vol 12 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Sivadasan Radha Anil ◽  
Kothandam Sivakumar ◽  
R. Krishna Kumar
Keyword(s):  
Pulmonary Artery ◽  
Venous Access ◽  
Color Flow ◽  
Arterial Access ◽  
Color Flow Imaging ◽  
Arterial Duct ◽  
Duct Diameter ◽  
Coil Occlusion ◽  
Doppler Color ◽  
Patent Arterial Duct

Background: Arterial access is traditionally considered mandatory during coil occlusion of the patent arterial duct. Arterial access necessitates heparinization and carries the risk of femoral artery occlusion in small children. Methods and Results: Between July 1999 and May 2001, we attempted coil occlusion of patent arterial ducts in 104 patients without arterial access. The patients were aged from 3 months to 14 years. The median age was 2 years. They weighed 3–35 kg. The median weight was 9.8 kg. The duct diameter at pulmonary artery insertion was 1.8–3.5 mm. The patients were selected on basis of echocardiographic evaluation of duct diameter at pulmonary artery insertion and morphology of the ampulla. Doppler color flow imaging was used in the catheterization laboratory to confirm duct closure. Arterial access was required in 21 patients. The reasons included accidental puncture in 5 patients, failure to obtain venous access in 1 patient, aortic embolization in 3 patients, poor echo images in 2 patients, requirement for additional coils in 8 patients and, failure to cross the duct from pulmonary artery in 2 patients. The fluoroscopic time ranged from 2.2 to 20 min with a mean of 5.3 ± 3.8 min. Immediate closure was achieved in 98 patients and this included 79 of the 83 patients in whom arterial access was avoided. Color Doppler 3–24 h later showed residual flow in 2 patients. Four patients had new-onset left pulmonary artery turbulence with peak gradients below 5 mm of mercury. Coil embolization occurred in 6 patients and all coils were retrieved. Three-month follow up information was available for 78 patients. Small residual ductal leaks were seen in 4 patients, 2 of whom had leaks at 24 h. Two patients had recanalized their ducts. Conclusion: It is feasible to occlude small patent arterial ducts with coils using venous access alone in carefully selected patients with excellent immediate and short-term results.

Closure of a patent arterial duct in a septuagenarian with atrial fibrillation

2004 ◽  
Vol 14 (3) ◽  
pp. 328-329 ◽  
Author(s):  
Konrad Brockmeier ◽  
Peter Hallscheidt ◽  
Christlieb Haller
Keyword(s):  
Atrial Fibrillation ◽  
Amplatzer Duct Occluder ◽  
Residual Shunt ◽  
Arterial Duct ◽  
Patent Arterial Duct

We occluded a large arterial duct in a patient with atrial fibrillation, using an Amplatzer duct occluder, with no residual shunt at the end of the procedure. Follow-up revealed recanalization, which was successfully treated with a 4 mm Amplatzer ASD occluder. It is speculated the reopening of the initially occluded duct was the consequence of anticoagulation needed because of the atrial fibrillation.

scholarly journals Device closure of pulmonary arteriovenous malformation using Amplatzer vascular plug II in hereditary hemorrhagic telangiectasia

2015 ◽  
Vol 67 (5) ◽  
pp. 455-458 ◽  
Author(s):  
Gopalan Nair Rajesh ◽  
Kalathingathodika Sajeer ◽  
Anishkumar Nair ◽  
Vellani Haridasan ◽  
Chakanalil Govindan Sajeev ◽  
...  
Keyword(s):  
Arteriovenous Malformation ◽  
Hereditary Hemorrhagic Telangiectasia ◽  
Amplatzer Vascular Plug ◽  
Pulmonary Arteriovenous Malformation ◽  
Device Closure ◽  
Vascular Plug ◽  
Amplatzer Vascular Plug Ii

Percutaneous closure of a patent arterial duct in a newborn

2009 ◽  
Vol 19 (4) ◽  
pp. 400-402
Author(s):  
Fredy H. Prada ◽  
Juan M. Carretero ◽  
Lorenzo Jimenez
Keyword(s):  
Critically Ill ◽  
Atrioventricular Block ◽  
Multiorgan Failure ◽  
Percutaneous Closure ◽  
Amplatzer Duct Occluder ◽  
Complete Atrioventricular Block ◽  
Arterial Duct ◽  
Critically Ill Neonates ◽  
Patent Arterial Duct ◽  
Complete Atrioventricular

AbstractWe report a successful percutaneous neonatal closure of haemodynamically significant patent arterial duct. The neonate was suffering multiorgan failure, and had complete atrioventricular block. Closure of the patent arterial duct, either with surgery or inhibitors of cyclooxygenase, was contraindicated. We inserted the Amplatzer Duct Occluder II, showing that percutaneous closure of a patent arterial duct is now feasible in critically ill neonates.

Sign in / Sign up

Export Citation Format

Share Document